Expertise Partner
SCARLETRED is the worldwide leader in standardized skin imaging and AI powered objective skin image analysis. We develop and supply cutting edge software products and services to biopharma-, biotech- , cosmetics companies, clinical research organisations and health care experts. Our certified, ICH-GCP and EU-GDPR compliant mobile medical device software Scarletred® Vision is the new skin imaging Gold Standard solving the problem of lacking standardization and subjective visual skin assessment in pre-clinical, clinical, and post-marketing studies. The highly scalable software platform works IT infrastructure and location independent and enables on-site and home-based monitoring of dermatologic disease as well as digital analysis of skin drug related effects. It it easy to use and reduces development time and opportunity cost in clinical RnD projects. Our digital Products and Services are delivered worldwide from our offices in Europe and USA via flexible Software as a Service (SaaS).
Event Partner
Symbio, LLC is a global full-service Clinical Research Organization (CRO) with a strong focus on Dermatology, Aesthetics and Inflammatory diseases. Managing all CRO core services in-house with offices in the USA and Europe. Delivering excellent service and providing experienced qualified personnel to strategically manage all aspects of your clinical trials. Symbio, LLC offers expertise in Proof-of-Concept, Medical Device and Phase 1 – Phase 4 clinical studies and has completed over 650+ clinical studies to date.
Event Partner
Integrated Solutions for Dermatology
NUVISAN is an established CRO whose expertise is bolstered by the pharmaceutical heritage of leading dermatology companies. We provide integrated services along the drug discovery and development value chain to support your projects in dermatology with flexible approaches for both start-ups and big pharma. From Drug Substance to Drug Product, our development capabilities cover all steps required for conceiving dermatological therapeutics as well as conducting targeted clinical studies.